FEC (5-fluorouracil, epidoxorubicin and cyclophosphamide) versus EM (epidoxorubicin and mitomycin-C) with or without lonidamine as first-line treatment for advanced breast cancer. A multicentric randomised study. Final results. (Q52076702)
Jump to navigation
Jump to search
scientific article published in May 2000
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | FEC (5-fluorouracil, epidoxorubicin and cyclophosphamide) versus EM (epidoxorubicin and mitomycin-C) with or without lonidamine as first-line treatment for advanced breast cancer. A multicentric randomised study. Final results. |
scientific article published in May 2000 |
Statements
1 reference
FEC (5-fluorouracil, epidoxorubicin and cyclophosphamide) versus EM (epidoxorubicin and mitomycin-C) with or without lonidamine as first-line treatment for advanced breast cancer. A multicentric randomised study. Final results. (English)
1 reference
Pacini P
1 reference
Rinaldini M
1 reference
Algeri R
1 reference
Guarneri A
1 reference
Tucci E
1 reference
Barsanti G
1 reference
Neri B
1 reference
Bastiani P
1 reference
Marzano S
1 reference
Fallai C
1 reference
1 May 2000
1 reference
36
1 reference
8
1 reference
966-975
1 reference
Identifiers
1 reference